Top-News
Pharmazeutika Irland

Endo International News

Aktie
WKN:  A1XE6M ISIN:  IE00BJ3V9050 US-Symbol:  ENDPQ
0,0006 $
+0,00 $
0,00%
01.05.24 20:16:01
Handeln Depot/Watchlist
Aktienanzahl *
235,22 Mio.
Marktkapitalisierung *
131,03 Tsd. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 28.05.2023

Endo International News

22.04.24 - PR Newswire
Par Pharmaceutical Issues Voluntary Nationwide Recall of Seven Lots of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution
Par Pharmaceutical Issues Voluntary Nationwide Recall of Seven Lots of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution PR Newswire
26.03.24 - PR Newswire
Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS®
Endo Launches Ibuprofen-​Famotidine Tablets, Generic Version of DUEXIS® PR Newswire
26.03.24 - PR Newswire
Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS®
Endo Launches Ibuprofen-​Famotidine Tablets, Generic Version of DUEXIS® PR Newswire
19.03.24 - PR Newswire
Endo Announces Confirmation of Plan of Reorganization
Endo Announces Confirmation of Plan of Reorganization PR Newswire
19.03.24 - PR Newswire
Endo Announces Confirmation of Plan of Reorganization
Endo Announces Confirmation of Plan of Reorganization PR Newswire
12.03.24 - PR Newswire
Par Pharmaceutical Issues Voluntary Nationwide Recall of One Lot of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution
Par Pharmaceutical Issues Voluntary Nationwide Recall of One Lot of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution PR Newswire
06.03.24 - PR Newswire
ENDO REPORTS FOURTH-QUARTER 2023 FINANCIAL RESULTS
ENDO REPORTS FOURTH-​QUARTER 2023 FINANCIAL RESULTS PR Newswire
06.03.24 - PR Newswire
ENDO REPORTS FOURTH-QUARTER 2023 FINANCIAL RESULTS
ENDO REPORTS FOURTH-​QUARTER 2023 FINANCIAL RESULTS PR Newswire
29.02.24 - PR Newswire
Endo Reaches Resolution with U.S. Department of Justice Regarding Legacy Marketing of Opana® ER
Endo Reaches Resolution with U.S. Department of Justice Regarding Legacy Marketing of Opana® ER PR Newswire
29.02.24 - PR Newswire
Endo Reaches Resolution with U.S. Department of Justice Regarding Legacy Marketing of Opana® ER
Endo Reaches Resolution with U.S. Department of Justice Regarding Legacy Marketing of Opana® ER PR Newswire
24.01.24 - PR Newswire
Endo Announces Publication of New XIAFLEX® (collagenase clostridium histolyticum) Survey Data in Journal of Hand Surgery Global Open
Endo Announces Publication of New XIAFLEX® (collagenase clostridium histolyticum) Survey Data in Journal of Hand Surgery Global Open PR Newswire
24.01.24 - PR Newswire
Endo Announces Publication of New XIAFLEX® (collagenase clostridium histolyticum) Survey Data in Journal of Hand Surgery Global Open
Endo Announces Publication of New XIAFLEX® (collagenase clostridium histolyticum) Survey Data in Journal of Hand Surgery Global Open PR Newswire
30.11.23 - PR Newswire
Endo Launches Unscripted Video Series With Real Peyronie's Disease Patients
Endo Launches Unscripted Video Series With Real Peyronie's Disease Patients PR Newswire
30.11.23 - PR Newswire
Endo Launches Unscripted Video Series With Real Peyronie's Disease Patients
Endo Launches Unscripted Video Series With Real Peyronie's Disease Patients PR Newswire
16.11.23 - PR Newswire
Endo Announces Five Presentations at the Sexual Medicine Society of North America (SMSNA) Annual Meeting
Endo Announces Five Presentations at the Sexual Medicine Society of North America (SMSNA) Annual Meeting PR Newswire
16.11.23 - PR Newswire
Endo Announces Five Presentations at the Sexual Medicine Society of North America (SMSNA) Annual Meeting
Endo Announces Five Presentations at the Sexual Medicine Society of North America (SMSNA) Annual Meeting PR Newswire
06.11.23 - PR Newswire
ENDO REPORTS THIRD-QUARTER 2023 FINANCIAL RESULTS
ENDO REPORTS THIRD-​QUARTER 2023 FINANCIAL RESULTS PR Newswire
06.11.23 - PR Newswire
ENDO REPORTS THIRD-QUARTER 2023 FINANCIAL RESULTS
ENDO REPORTS THIRD-​QUARTER 2023 FINANCIAL RESULTS PR Newswire
21.09.23 - PR Newswire
Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting
Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting PR Newswire
21.09.23 - PR Newswire
Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting
Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting PR Newswire

Newssuche

Videos

07.05.24 -4,91%
Technical Trading: DAX Long kurzfristig
DAX Long Typ: Turbo Open End WKN: NG8K9X Hebel: 26 Laufzeit: OpenEnd Einstieg: Market ... Mehr »